Lord Abbett Health Care R3 (LHCQX)
| Fund Assets | 8.67M |
| Expense Ratio | 1.28% |
| Min. Investment | $0.00 |
| Turnover | 91.00% |
| Dividend (ttm) | 0.06 |
| Dividend Yield | 0.28% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 23.63 |
| YTD Return | 7.45% |
| 1-Year Return | 33.69% |
| 5-Year Return | 24.15% |
| 52-Week Low | 17.73 |
| 52-Week High | 23.90 |
| Beta (5Y) | n/a |
| Holdings | 60 |
| Inception Date | Jul 31, 2019 |
About LHCQX
Lord Abbett Health Care Fund Class R3 is a mutual fund designed to provide long-term capital growth by investing primarily in equities of companies within the healthcare sector. The fund seeks to capture opportunities across a broad spectrum of healthcare industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services. It is managed by Lord Abbett, a firm known for its active management approach. Notable characteristics include a focus on both large, established industry leaders and innovative growth companies poised to benefit from advances in medical science and changes in healthcare delivery. The fund’s portfolio is diversified across various subsectors, which can help manage risks specific to the healthcare field. Lord Abbett Health Care Fund Class R3 plays a significant role in the financial market by offering investors targeted exposure to healthcare, a sector known for its resilience and growth potential driven by demographic trends, technological advancements, and evolving global health needs.
Performance
LHCQX had a total return of 33.69% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.99%.
Top 10 Holdings
38.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.06% |
| AstraZeneca PLC | AZN | 4.82% |
| Gilead Sciences, Inc. | GILD | 4.33% |
| Johnson & Johnson | JNJ | 3.25% |
| Nektar Therapeutics | NKTR | 3.23% |
| Natera, Inc. | NTRA | 2.97% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.88% |
| Guardant Health, Inc. | GH | 2.68% |
| argenx SE | ARGX | 2.61% |
| Novartis AG | NOVN | 2.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Nov 26, 2024 | $0.0648 | Nov 26, 2024 |
| Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
| Nov 24, 2020 | $2.3119 | Nov 24, 2020 |